Glycoprotein Peptide
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
-
- Target
- Glycoprotein
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- DENDWNEKLY PVWKRGDMRW KNSWKGGRVQ AVLTSDSPAL VGSNITFAVN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GPNMB antibody,
Alternative Names: Glycoprotein control peptide, Glycoprotein antibody Blocking Peptide, Anti-Glycoprotein Blocking Peptide, HGFIN Blocking Peptide, NMB Blocking Peptide, Transmembrane Nmb Blocking Peptide, GPNMB Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Glycoprotein
- Synonyms
- glycoprotein Peptide, Glycoprotein Peptide, transmembrane glycoprotein G Peptide, G Peptide, RVFV_sM_gp1 Peptide, RABVgp4 Peptide
- Target Type
- Viral Protein
- Background
- GPNMB is a type I transmembrane glycoprotein which shows homology to the pMEL17 precursor, a melanocyte-specific protein. GPNMB shows expression in the lowly metastatic human melanoma cell lines and xenografts but does not show expression in the highly metastatic cell lines. GPNMB may be involved in growth delay and reduction of metastatic potential.
- Molecular Weight
- 60 kDa
-
You are here:
